Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Houssem Khanfir"'
Publikováno v:
BMC Cardiovascular Disorders, Vol 19, Iss 1, Pp 1-11 (2019)
Abstract Background Despite currently available treatments, the burden of myocardial infarction (MI) morbidity and mortality remains prominent. The aim of this was to investigate the risk of developing subsequent cardiovascular events in MI patients.
Externí odkaz:
https://doaj.org/article/427ee48af8b443269d88b301e928edd2
Autor:
Juha Mehtälä, Jihong Zong, Zdravko Vassilev, Gunnar Brobert, Montse Soriano Gabarró, Pär Stattin, Houssem Khanfir
Publikováno v:
PLoS ONE, Vol 15, Iss 2, p e0227552 (2020)
BACKGROUND:Among prostate cancer (PC) patients, over 90% of distant metastases occur in the bone. PC treatments may be associated with side effects, including second primary malignancies (SPM). There is limited information on the incidence of SPM amo
Externí odkaz:
https://doaj.org/article/e83d93f64e39495a97f8ca7bcecd8cbd
Publikováno v:
European Journal of Clinical Pharmacology. 76:257-265
Purpose Use of oral antiplatelets (OAPs) is essential for preventing thrombotic events in patients with acute coronary syndrome (ACS). Effects of clopidogrel, prasugrel, and ticagrelor may be enhanced due to pharmacodynamic interactions, but as CYP s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e668f768a90b455186dd4d0a6c31173c
https://doi.org/10.1007/s00228-019-02777-z
https://doi.org/10.1007/s00228-019-02777-z
Autor:
Montse Soriano Gabarró, Jihong Zong, Juha Mehtälä, Houssem Khanfir, Gunnar Brobert, Zdravko P. Vassilev, Pär Stattin
Publikováno v:
PLoS ONE, Vol 15, Iss 2, p e0227552 (2020)
PLoS ONE
PLoS ONE
Background Among prostate cancer (PC) patients, over 90% of distant metastases occur in the bone. PC treatments may be associated with side effects, including second primary malignancies (SPM). There is limited information on the incidence of SPM amo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5cc73e217c2336cefed04a3361bf0c15
https://doaj.org/article/e83d93f64e39495a97f8ca7bcecd8cbd
https://doaj.org/article/e83d93f64e39495a97f8ca7bcecd8cbd
Autor:
Pasi K. Korhonen, Juha Mehtälä, Fabian Hoti, Riitta Lassila, Mika Lehto, Houssem Khanfir, Jussi Niiranen, M.J. Pekka Raatikainen
Publikováno v:
Pharmacoepidemiology and Drug Safety. 26:657-665
Purpose The most important management strategy in atrial fibrillation (AF) patients is preventing stroke with oral anticoagulants. Warfarin is still used as a first-line anticoagulant, although non-vitamin K antagonist oral anticoagulants are current
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0f83409fb0d0eda1abe8321df473e758
https://doi.org/10.1002/pds.4194
https://doi.org/10.1002/pds.4194
Autor:
Pekka Raatikainen, Mika Lehto, Houssem Khanfir, Jukka Putaala, Paula Tiili, Juha Mehtälä, Jussi Niiranen, Pasi K. Korhonen
Background Intracranial hemorrhage (ICH) is a devastating complication of oral anticoagulation. The aim of this study was to describe the spectrum of ICH and to evaluate the association of warfarin control with the risk of ICH in a nationwide cohort
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c728c1a1d50d09c2da3ac2688ee4a859
http://hdl.handle.net/10138/299969
http://hdl.handle.net/10138/299969
Autor:
Houssem Khanfir, Tero Penttilä, Riitta Lassila, Pekka Raatikainen, Juha Mehtälä, Mika Lehto, Jussi Niiranen
Aims Females with atrial fibrillation (AF) have been suggested to carry a higher risk for thromboembolic events than males. We compared the residual risk of stroke, bleeding events, and cardiovascular and all-cause mortality among female and male AF
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::054c45be5acfeaaeb3070ee580fb4c88
http://hdl.handle.net/10138/314535
http://hdl.handle.net/10138/314535
Autor:
KytĂś, Ville, Prami, Tuire, Houssem Khanfir, PĂĽl Hasvold, Reissell, Eeva, Airaksinen, Juhani
Table S1. Adjusted hazard ratios for predictors of primary outcomes in total study and stable post-MI populations. (DOCX 115 kb)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::320b413cb231c60c403240c4c17bae52
BACKGROUND: Studies investigating bladder cancer risk in pioglitazone-treated type 2 diabetes mellitus patients report conflicting results. Previous meta-analyses on this topic utilized publications prior to 2013. More long-term observational studies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1244480c511d13118c89a969a1190594
https://europepmc.org/articles/PMC6357234/
https://europepmc.org/articles/PMC6357234/
Autor:
Arto Y. Strandberg, Timo E. Strandberg, Fabian Hoti, Houssem Khanfir, Tero Saukkonen, Sari Mäkimattila
Publikováno v:
Annals of medicine. 49(4)
The longer acting basal insulin analogs glargine and detemir have shown a lower incidence of hypoglycemia compared to insulin NPH in clinical studies. We evaluated the real-life risk of severe hypoglycemia among new users of insulins in the working-a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18006ce7d1faaa87a4bc1615520b8d86
https://pubmed.ncbi.nlm.nih.gov/28042719
https://pubmed.ncbi.nlm.nih.gov/28042719